Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen, Mir Lim, Katharina Pomej, Tiziana Pressiani, Antonella Cammarota, Thorben W. Fründt, Johann von Felden, Kornelius Schulze, Vera Himmelsbach, Fabian Finkelmeier, Ansgar Deibel, Alexander R. Siebenhüner, Kateryna Shmanko, Pompilia Radu, Birgit Schwacha-Eipper, Matthias P. Ebert, Andreas Teufel, Angela Djanani, Florian Hucke, Lorenz Balcar, Alexander B. Philipp, David Hsiehchen, Marino Venerito, Friedrich Sinner, Michael Trauner, Antonio D'Alessio, Claudia A.M. Fulgenzi, David J. Pinato, Markus Peck-Radosavljevic, Jean-François Dufour, Arndt Weinmann, Andreas E. Kremer, Amit G. Singal, Enrico N. De Toni, Lorenza Rimassa, Matthias Pinter

Open source

DOI: 10.1016/j.jhepr.2022.100620
Published: 2023-01
Container: JHEP Reports
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2022.100620,
  title = {Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma},
  author = {Bernhard Scheiner and Daniel Roessler and Samuel Phen and Mir Lim and Katharina Pomej and Tiziana Pressiani and Antonella Cammarota and Thorben W. Fründt and Johann von Felden and Kornelius Schulze and Vera Himmelsbach and Fabian Finkelmeier and Ansgar Deibel and Alexander R. Siebenhüner and Kateryna Shmanko and Pompilia Radu and Birgit Schwacha-Eipper and Matthias P. Ebert and Andreas Teufel and Angela Djanani and Florian Hucke and Lorenz Balcar and Alexander B. Philipp and David Hsiehchen and Marino Venerito and Friedrich Sinner and Michael Trauner and Antonio D'Alessio and Claudia A.M. Fulgenzi and David J. Pinato and Markus Peck-Radosavljevic and Jean-François Dufour and Arndt Weinmann and Andreas E. Kremer and Amit G. Singal and Enrico N. De Toni and Lorenza Rimassa and Matthias Pinter},
  year = {2023},
  journal = {JHEP Reports},
  doi = {10.1016/j.jhepr.2022.100620},
  url = {https://doi.org/10.1016/j.jhepr.2022.100620}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
AU  - Bernhard Scheiner
AU  - Daniel Roessler
AU  - Samuel Phen
AU  - Mir Lim
AU  - Katharina Pomej
AU  - Tiziana Pressiani
AU  - Antonella Cammarota
AU  - Thorben W. Fründt
AU  - Johann von Felden
AU  - Kornelius Schulze
AU  - Vera Himmelsbach
AU  - Fabian Finkelmeier
AU  - Ansgar Deibel
AU  - Alexander R. Siebenhüner
AU  - Kateryna Shmanko
AU  - Pompilia Radu
AU  - Birgit Schwacha-Eipper
AU  - Matthias P. Ebert
AU  - Andreas Teufel
AU  - Angela Djanani
AU  - Florian Hucke
AU  - Lorenz Balcar
AU  - Alexander B. Philipp
AU  - David Hsiehchen
AU  - Marino Venerito
AU  - Friedrich Sinner
AU  - Michael Trauner
AU  - Antonio D'Alessio
AU  - Claudia A.M. Fulgenzi
AU  - David J. Pinato
AU  - Markus Peck-Radosavljevic
AU  - Jean-François Dufour
AU  - Arndt Weinmann
AU  - Andreas E. Kremer
AU  - Amit G. Singal
AU  - Enrico N. De Toni
AU  - Lorenza Rimassa
AU  - Matthias Pinter
PY  - 2023
JO  - JHEP Reports
DO  - 10.1016/j.jhepr.2022.100620
UR  - https://doi.org/10.1016/j.jhepr.2022.100620
ER  -

APA

Scheiner, B., Roessler, D., Phen, S., Lim, M., Pomej, K., Pressiani, T., Cammarota, A., Fründt, T. W., Felden, J. V., Schulze, K., Himmelsbach, V., Finkelmeier, F., Deibel, A., Siebenhüner, A. R., Shmanko, K., Radu, P., Schwacha-Eipper, B., Ebert, M. P., Teufel, A., Djanani, A., Hucke, F., Balcar, L., Philipp, A. B., Hsiehchen, D., Venerito, M., Sinner, F., Trauner, M., D'Alessio, A., Fulgenzi, C. A., Pinato, D. J., Peck-Radosavljevic, M., Dufour, J., Weinmann, A., Kremer, A. E., Singal, A. G., Toni, E. N. D., Rimassa, L., & Pinter, M. (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma. JHEP Reports. https://doi.org/10.1016/j.jhepr.2022.100620

Source records

crossref · retrieved 2026-09-26T12:24:20.265Z